Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

Leukemia is classified by stage. Different types of leukemia (acute vs. chronic) have different staging systems—with some with as few as three stages and others with as many as seven—but each ...

Background: Leukemia is the 11 th most prevalent type of cancer worldwide, with acute myeloid leukemia (AML) being the most frequent malignant blood malignancy in adults. Microscopic blood tests are ...

Acute kidney injury (AKI) is a common, heterogeneous, multifactorial condition, which is part of the overarching syndrome of acute kidney diseases and disorders. This condition’s incidence highest in ...

iDivision of Nephrology, Department of Medicine, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada jDepartment of Community Health Sciences, O ...

Information on treatment success rates for AML in adults can be found in Treatment Response Rates for Acute Myeloid Leukemia. Our team is made up of doctors and oncology certified nurses with deep ...